Skip to Content
Severe eczema holding you back? Find the right treatment

Penicillin g benzathine / procaine penicillin Pregnancy and Breastfeeding Warnings

Penicillin g benzathine / procaine penicillin is also known as: Bicillin C-R, Bicillin C-R 900/300

Penicillin g benzathine / procaine penicillin Pregnancy Warnings

Animal studies have failed to reveal evidence of fetal harm due to penicillin G. No positive evidence of adverse effects on the fetus observed during human use of penicillins; however, there are no controlled data in human pregnancy. US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

This drug should be used during pregnancy only if clearly needed. US FDA pregnancy category: Not assigned.

See references

Penicillin g benzathine / procaine penicillin Breastfeeding Warnings

Use is considered acceptable; caution is recommended. Excreted into human milk: Yes Comments: -The effects in the nursing infant are unknown. -Limited data indicate that low levels in milk from single maternal doses are not expected to cause harmful effects in nursing infants.

Soluble penicillin G is excreted in breast milk. Single or multiple doses of penicillin G (100,000 units IM once or every 2 hours for 6 hours) were administered to 10 women. At 1 to 2 hours after dosing, milk levels ranged from unmeasurable to 30 units/L after a single dose and averaged 50 units/L after multiple doses. A single IM dose of penicillin G was administered to 10 women. Milk levels were about 60 units/L and relatively constant for 6 hours after a 200,000-unit dose in 4 women. At 2 to 4 hours after a 500,000-unit dose in 4 women, milk levels reached 240 units/L. Peak levels of 240 to 360 units/L occurred at 4 hours after a 600,000-unit dose in 2 women. After 2 IM doses (2 million units/dose) of penicillin G in 15 women, peak and trough milk levels were 120 and 10 units/L, respectively. After 2 IM doses (4 million units/dose) in 5 women, peak and trough milk levels were 220 and 30 units/L, respectively. Peak levels occurred 3 to 6 hours postdose. After an IM dose of 360 mg (about 550,000 units) of penicillin G in 2 women, milk levels averaged 0.35 mg/L (530 units/L) at 1 hour, 0.2 mg/L (300 units/L) at 2 hours, and 0.1 mg/L (150 units/L) at 4 hours after dosing; at 6 hours postdose, only a trace was detectable. A Herxheimer reaction occurred in a 1-month-old breastfed infant with congenital syphilis 6 hours after a 2.4 million unit IM dose of benzathine penicillin G was administered to the mother; the infant had also received 10 units of penicillin G at about the time of the maternal dose. The reaction was possibly due to penicillin in breast milk. Disruption of infant's gastrointestinal flora (resulting in diarrhea or thrush) reported occasionally with penicillins; such effects have not been adequately evaluated.

See references

References for pregnancy information

  1. "Product Information. Bicillin C-R (benzathine penicillin-procaine penicillin)." A-S Medication Solutions, Chicago, IL.
  2. "Product Information. Bicillin C-R 900/300 (benzathine penicillin-procaine penicillin)." Wyeth Laboratories, Philadelphia, PA.

References for breastfeeding information

  1. "Product Information. Bicillin C-R (benzathine penicillin-procaine penicillin)." A-S Medication Solutions, Chicago, IL.
  2. "Product Information. Bicillin C-R 900/300 (benzathine penicillin-procaine penicillin)." Wyeth Laboratories, Philadelphia, PA.
  3. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide